Document is current
Any future updates will be listed below
-
Authors
Kolb, Hubert
Kempf, Kerstin
Röhling, Martin
Martin, Stephan
- License Information
-
More Information
Article History
Received: 4 May 2020
Accepted: 29 June 2020
First Online: 21 August 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: S. Martin has received non-restricted support for the conduct of trials of lifestyle change in persons at risk or with type 2 diabetes by Novartis Pharma GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Almased Wellness GmbH, Nintendo of Europe GmbH, HMM Holding AG, and Gesellschaft von Freunden und Förderern der Heinrich-Heine-Universität Düsseldorf e.V.. H. Kolb, K. Kempf, and M. Röhling have nothing to disclose.
